NL
Nuveen LLC Portfolio holdings
AUM
$362B
This Quarter Return
-3.57%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$330B
AUM Growth
–
Cap. Flow
+$329B
Cap. Flow
% of AUM
99.82%
Top 10 Holdings %
Top 10 Hldgs %
28%
Holding
3,279
New
3,246
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Microsoft
MSFT
|
$18.7B |
| 2 |
Apple
AAPL
|
$17.5B |
| 3 |
NVIDIA
NVDA
|
$15.1B |
| 4 |
Amazon
AMZN
|
$11.7B |
| 5 |
Broadcom
AVGO
|
$6.65B |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 28.46% |
| 2 | Financials | 13.55% |
| 3 | Healthcare | 11.18% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Everspin Technologies
MRAM
$147M
| $133K | ﹤0.01% |
+25,997
| New | +$133K |
|
3152
Stereotaxis
STXS
$264M
| $130K | ﹤0.01% |
+73,990
| New | +$130K |
|
|
THRD
3153
DELISTED
Third Harmonic Bio
THRD
| $129K | ﹤0.01% |
+37,246
| New | +$129K |
|
3154
INmune Bio
INMB
$51.8M
| $129K | ﹤0.01% |
+16,518
| New | +$129K |
|
3155
Tenaya Therapeutics
TNYA
$220M
| $129K | ﹤0.01% |
+226,202
| New | +$129K |
|
3156
Waldencast
WALD
$219M
| $128K | ﹤0.01% |
+42,770
| New | +$128K |
|
3157
WM Technology
MAPS
$126M
| $126K | ﹤0.01% |
+111,832
| New | +$126K |
|
|
MAZE
3158
Maze Therapeutics, Inc. Common Stock
MAZE
$696M
| $125K | ﹤0.01% |
+11,375
| New | +$125K |
|
3159
Lexeo Therapeutics
LXEO
$271M
| $125K | ﹤0.01% |
+36,050
| New | +$125K |
|
3160
Pyxis Oncology
PYXS
$118M
| $125K | ﹤0.01% |
+127,304
| New | +$125K |
|
3161
Achieve Life Sciences
ACHV
$145M
| $125K | ﹤0.01% |
+46,668
| New | +$125K |
|
3162
Perma-Fix Environmental Services
PESI
$223M
| $123K | ﹤0.01% |
+16,895
| New | +$123K |
|
3163
Traeger
COOK
$200M
| $122K | ﹤0.01% |
+72,790
| New | +$122K |
|
3164
Geospace Technologies
GEOS
$231M
| $120K | ﹤0.01% |
+16,684
| New | +$120K |
|
|
BIOA
3165
BioAge Labs, Inc. Common Stock
BIOA
$171M
| $118K | ﹤0.01% |
+55,406
| New | +$118K |
|
3166
Ultralife
ULBI
$119M
| $116K | ﹤0.01% |
+21,647
| New | +$116K |
|
3167
Atossa Therapeutics
ATOS
$102M
| $115K | ﹤0.01% |
+170,733
| New | +$115K |
|
3168
Twin Disc
TWIN
$184M
| $114K | ﹤0.01% |
+15,002
| New | +$114K |
|
3169
Zynex
ZYXI
$45.1M
| $110K | ﹤0.01% |
+49,860
| New | +$110K |
|
3170
Vera Bradley
VRA
$60.6M
| $110K | ﹤0.01% |
+48,692
| New | +$110K |
|
3171
Northern Technologies International Corp
NTIC
$73.4M
| $109K | ﹤0.01% |
+10,495
| New | +$109K |
|
|
MBX
3172
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $107K | ﹤0.01% |
+14,471
| New | +$107K |
|
|
ALMS
3173
Alumis Inc. Common Stock
ALMS
$469M
| $105K | ﹤0.01% |
+17,097
| New | +$105K |
|
3174
1stdibs.com
DIBS
$100M
| $103K | ﹤0.01% |
+33,826
| New | +$103K |
|
3175
ALX Oncology
ALXO
$65.3M
| $103K | ﹤0.01% |
+164,790
| New | +$103K |
|